Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Autonomix Medical, Inc. (AMIX) just unveiled an announcement.
Autonomix Medical, Inc. has reported encouraging early results from a clinical trial assessing a new treatment that could alleviate pancreatic cancer pain by targeting specific nerves. The announcement, made on June 18, 2024, highlighted the success of the first five patients in a proof-of-concept study. These findings were also presented in a webcast, underlining the company’s progress in developing potentially groundbreaking pain mitigation therapies.
See more data about AMIX stock on TipRanks’ Stock Analysis page.